EU PERSPECTIVES - People in the Netherlands, Greece, and Italy are dying form West Nile virus infection. Europe has no specific treatment against it, Brussels has confirmed. Read more

EURACTIV - Over the next decade, a wave of biologic medicines will lose patent protection in Europe, but unlike the past ten years, biosimilar competition and the savings and access it brought are no longer guaranteed to follow. Read more

EU PERSPECTIVES - The biggest overhaul of Europe's pharmaceutical law in two decades is to arrive this autumn, with a two-year transition. Lawyer Hein van den Bos explains to EU Perspectives what changes, what the debate missed, and why anything now in development is already affected. Read more

EURACTIV - Belgium does not spend unusually little on medicines compared with its larger neighbours. It spends the money badly, argues Professor Walter Van Dyck. The economist says Belgium cuts prices hard to stay within a tight budget today, then pays later in lost innovation. Read more

EU PERSPECTIVES - New medicines are reaching Europe later than the US. A recent study says two separate policies are to blame, and that the damage is the worst when they meet. Read more

EU PERSPECTIVES - A cancer treatment can clear Europe-wide approval, yet patient access still varies enormously from one country to the next. The difference is as much as three years, Isabel Rubio, the president of the European Cancer Organisation tells EU Perspectives. Read more

EU PERSPECTIVES - For the second year running, member states have refused to sign off the EU4Health budget 2026, over cuts to core funding for health NGOs. EUPHA (European Public Health Association) president Tit Albreht spoke to EU Perspectives about why public health cannot turn to industry money, and what Europe loses if it lets health funding...

EU PERSPECTIVES - Artificial intelligence (AI) is scanning breasts in Turkey, reading X-rays in Portugal and phoning elderly patients at home. The technology has arrived. The rules to govern it are being drafted elsewhere, and health is not at the table. Read more

EU PERSPECTIVES - Some pharmaceutical companies are openly warning that they could delay bringing their medicines to Europe. Solène Jouan is not willing to accept it. The policy officer at the European Patients' Forum believes such warnings place undue pressure on member states and already overstretched health systems. Ultimately, she argues, the...

EURACTIV - With global attention turning to expanding HIV prevention, Médecins Sans Frontières (MSF) is urging governments worldwide to ensure the twice-yearly drug lenacapavir becomes affordable and widely accessible. Its Belgian section made the appeal from Brussels during the 26th International AIDS Conference in Rio de Janeiro, calling on the...